Latest News

Regeneron Partners With Westwood & Wilshire to Fill Senior Director, Clinical Development

Tolga Baykal has joined Regeneron as Senior Director, Clinical Development. Dr. Baykal joins Regeneron from Shionogi where she served as Medical Lead, Clinical Development, Antivirals & Anti-infectives. Dr. Baykal has held positions of increasing related responsibility at Eli Lilly, Abbott/AbbVie, and Intercept.

The search was successfully led by Julie McDonald at Westwood & Wilshire.

 

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.

Agios Partners With Westwood & Wilshire to Fill Medical Director Hematology

Thomas Winkler has joined Agios as Medical Director Hematology. Dr. Winkler joins Agios from the National Institutes of Health (NIH) where he served as Staff Clinician. In addition to a MD from Medizinische Hochschule Hannover, Dr. Winkler has held positions of increasing related responsibility at National Institutes of Health (NIH) throughout his career.

The search was successfully led by Chris Tillman at Westwood & Wilshire.

 

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.

Astellas Partners With Westwood & Wilshire to Fill Associate Director of Medical Safety

Shaka Martin has joined Astellas Pharma as Associate Director of Medical Safety. Dr. Martin joins Astellas after consulting for Tesaro where he was their leading Safety Physician. In addition to a MD from Palacky University Medical Faculty, Dr. Martin has held positions of increasing related responsibility at Boston Biomedical Inc., Ironwood Pharmaceuticals, Merck Kgaa – Serono, and Seqirus Pharmaceuticals. 

The search was successfully led by Gerard Danishek at Westwood & Wilshire.

 At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.

Regeneron Partners With Westwood & Wilshire to Fill Associate Director, Clinical Sciences Immunology

Angeliki Giannelou has joined Regeneron as Associate Director, Clinical Sciences Immunology. Dr. Giannelou joins Regeneron from the National Institute of Arthritis and Musculoskeletal and Skin Diseases -(NIAMS)/NIH where she served as a Visiting Research Fellow. In addition to a MD from the University of Patra, Dr. Giannelou has held positions of increasing related responsibility at NIAMS throughout her career.

The search was successfully led by Julie McDonald at Westwood & Wilshire.

 

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.

Agios Partners With Westwood & Wilshire to Fill Head of Rare Disease Clinical Development

Chris Mix has joined Agios as Head of Rare Disease Clinical Development. Dr. Mix joins Agios from Sarepta Therapeutics where he served as Executive Medical Director, Global Development and Head of Clinical Development. In addition to a MD from the University of Massachusetts, Dr. Mix has held positions of increasing related responsibility at Tufts New England Medical Center, Amgen, and Alexion.

The search was successfully led by Tamir Halaban at Westwood & Wilshire.

 

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California with additional offices in Silicon Valley, we serve our clients on a local, national and global basis.